To get a sense of who is truly in control of Alcon Inc. ( VTX:ALC ), it is important to understand the ownership structure of ...

In this article, we are going to take a look at where Alcon Inc. (NYSE:ALC) stands against Oppenheimer's other favorite ...

Alcon Inc.’s ALC growth is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. However, concerns remain about the macroeconomic headwinds ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Alcon, Inc. (NYSE: ALC) delivered core earnings per share of 74 cents in the second quarter of 2024, up 7.2% from the year-ago quarter's figure (up 15% at the constant exchange rate or CER).

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

Begin your TipRanks Premium journey today. Alcon (ALC) Company Description: Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures ...

On Thursday, Redburn-Atlantic revised its rating on Alcon Inc. (NYSE:ALC:SW) (NYSE: ALC), lifting the stock from Sell to Neutral and increasing the price target to CHF78.00 from CHF68.00.

On Thursday, Redburn-Atlantic revised its rating on Alcon Inc. (NYSE:ALC:SW) (NYSE: ALC), lifting the stock from Sell to Neutral and increasing the price target to CHF78.00 from CHF68.00. The upgrade ...